Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
price target raised at Barclays to $39 from $35 as the analog leader delivered another strong quarter with results above estimates and a $1 billion buyback plan on the way, Barclays said. Reiterate Overweight rating.
estimates increased at Goldman through 2011. Company is realizing higher margins. Buy rating and $38 price target.
Ann Taylor Stores
price target higher at BofA/Merrill. ANN price target increased to $30 from $28. Momentum impressive and Loft improving, Bank of America/Merrill Lynch said. Maintain Buy rating.
numbers boosted at Goldman. Shares of BBY now seen reaching $48, according to Goldman Sachs. Estimates also upped, as the company will likely repurchase more stock. Neutral rating.
estimates, target lowered at Goldman. BRCD estimates were cut through 2012, Goldman Sachs said. IT infrastructure demand is slowing and Federal business could remain soft. Neutral rating and new $5.50 price target.
Capitol Federal Financial
price target cut at Barclays. CFFN price target sunk to $26 from $43 as the company is converting to full public ownership. The company's previous conversion attempt in August failed due to lack of demand, Barclays said. Maintain Overweight rating.
target upped at Argus to $270. Company should continue to deliver solid growth. Buy rating.
estimates, target reduced at Citigroup. CPN estimates were cut through 2011, Citigroup said. Company is facing lower spark spreads. Buy rating and new $15 price target.
price target increased at BofA/Merrill to $85 from $80. Upside production potential secured, Bank of America/Merrill Lynch said. Reiterate Buy rating.
estimates, target boosted at UBS. Shares of HES now seen reaching $78, according to UBS. Estimates also upped, as the recent Bakken purchase should ad to earnings. Buy rating.
price target boosted at Credit Suisse. HON price target raised to $60 from $55 on continued recovery in Aerospace and a recent change in pension accounting, Barclays said. Maintain Overweight rating.
price target higher at Barclays to $53 from $50 as new CEO Apotheker is performing better than expected, Barclays said. Maintain Overweight rating.
estimates increased at UBS through 2012. Company is seeing better sales and buying back stock. Neutral rating and $48 price target.
numbers raised at Morgan Stanley. Shares of HPQ now seen reaching $57. Estimates also increased, as the company is gaining market share. Overweight rating.
estimates, target raised at Piper. Shares of NFLX now seen reaching $202, according to Piper Jaffray. Estimates also increased, given the company's new pricing plan. Overweight rating.
price target increased at BofA/Merrill. NKE price target raised to $95 from $90. Sneaker costs staying low, Bank of America/Merrill Lynch said.
estimates lowered at RBC. POT estimates were reduced through 2012. New debt offering will cut into earnings. Outperform rating.
price target boosted at Credit Suisse. SO price target increased to $39 from $37. Pleased by Georgia's best in class regulatory environment, Barclays said. Maintain Neutral rating.
price target boosted at BofA/Merrill to $30 from $24 as strong production trends in auto continue, Bank of America/Merrill lynch said. Reiterate Buy rating.
numbers upped at Citigroup. TECD estimates were boosted through 2012. Company is realizing better operating leverage. Buy rating and new $60 price target.
price target lifted at BofA/Merrill. UA price target increased to $58 from $54. Favorable athletic footwear product cycle. Bank of America/Merrill Lynch said .
estimates, target raised at Goldman. Shares of VAL now seen reaching $37, according to Goldman Sachs. Estimates also increased, to match the company's new guidance. Neutral rating.
This article was written by a staff member of TheStreet.